Peer-reviewed veterinary case report
Functional breathing tests linked to inflammation and treatment
By Lin, C-H et al.·Published in Journal of veterinary internal medicine·2015·Graduate Institute of Veterinary Medicine·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Functional phenotype and its correlation with therapeutic response and inflammatory type of bronchoalveolar lavage fluid in feline lower airway disease.
- Species:
- cat
Plain-English summary
A group of 19 cats with feline lower airway disease (FLAD) were treated with daily glucocorticoids to help improve their breathing. Before and after treatment, the cats underwent tests to measure their airflow and the type of inflammation in their lungs. After treatment, the tests showed significant improvement in airflow, indicating that the glucocorticoids were effective. The study found that certain measurements of airflow were closely linked to the type of inflammatory cells present in the cats' lungs, which can help vets monitor how well the treatment is working.
People also search for: cat breathing problems treatment · feline lower airway disease glucocorticoids · cat asthma symptoms and treatment
Abstract
BACKGROUND: Currently, functional assessment to monitor therapeutic response in feline lower airway disease (FLAD) has limited application. OBJECTIVES: To evaluate if expiratory indices derived from pseudo-tidal breathing flow-volume loop (pTBFVL) representing lower airway obstruction would decrease after clinical improvement and to investigate the correlation between functional phenotype and inflammatory cell type in bronchoalveolar lavage (BAL) fluid. ANIMALS: Nineteen client-owned cats with FLAD. METHODS: Prospective observational study. Functional assessment with pTBFVL indices (eg, peak to mid-expiratory flow; PEF/EF50) and conventional barometric whole body plethysmography (BWBP) parameters (eg, enhanced pause) was carried out before receiving treatment. BAL was performed to analyze inflammatory cell types. Signs were assessed by scoring. The cats were treated with glucocorticoids daily and functional testing was repeated. RESULTS: Loop indices PEF/EF50 and PEF/EF25 were significantly decreased after treatment (P < .001). Conventional BWBP parameters were not significantly different before and after treatment. Cats with PEF/EF50 > 1.51 before treatment had a significantly higher granulocyte (eosinophil plus neutrophil) percentage in BAL fluid (P = .014). Granulocyte percentage in BAL fluid was strongly correlated with PEF/EF25 (P = .001, rs = 0.74) and moderately correlated with PEF/EF50 (P = .022, rs = 0.57), whereas eosinophil or neutrophil percentage alone had no significant correlation with functional parameters. CONCLUSIONS AND CLINICAL IMPORTANCE: Functional parameters including PEF/EF50 and PEF/EF25 can be used for monitoring therapeutic response. The presence of airflow limitation during mid- to late expiration is affected by the overall extent of granulocyte infiltration.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/25417806/